(Clin Microbiol Infect[TA])
9,277 results
  • Chimeric antigen receptor (CAR) therapy in infectious diseases: emerging applications with a focus on invasive fungal infections. [Review]
    Clin Microbiol Infect. 2026 Aug 17. [Online ahead of print]Bracke C, Grafia I, Puerta-Alcalde PCM
  • CONCLUSIONS: CAR-based immunotherapy represents a novel and potentially transformative approach for the management of severe infections in immunocompromised patients, particularly those with refractory or multidrug-resistant disease. Advances in manufacturing, target selection, and combination strategies will be essential to overcome current limitations. Further clinical studies are needed to define their safety, efficacy, and positioning within existing therapeutic frameworks.
  • An Introduction to the Machine Learning Lifecycle for Clinical Microbiology. [Review]
    Clin Microbiol Infect. 2026 Aug 15. [Online ahead of print]Lboukili I, McFadden BR, … Brüningk SCCM
  • CONCLUSIONS: Successful AI implementation in microbiology demands alignment with laboratory workflows, transparency and interpretability of model behavior, robust performance under real-world variability, and strong data governance. Addressing these factors is essential for translating promising methodological advances into solutions to enhance diagnostics, antimicrobial stewardship, and infection prevention.
  • Immunomodulating treatments for bacterial meningitis and viral encephalitis. [Review]
    Clin Microbiol Infect. 2026 Aug 14. [Online ahead of print]Brouwer MC, van de Beek DCM
  • CONCLUSIONS: Studies on the modulation of the inflammatory response in bacterial meningitis showed adjunctive dexamethasone should be routinely used in patients with community-acquired bacterial meningitis. Other immunomodulating treatments in bacterial meningitis are currently not advised. There is no convincing evidence for immunosuppressive treatment in patients with viral encephalitis. Whether early corticosteroid treatment is beneficial in HSV encephalitis should be evaluated in a new RCT.
  • Herpes Zoster vaccination coverage and its determinants in older adults: A Meta-analysis. [Review]
    Clin Microbiol Infect. 2026 Aug 13. [Online ahead of print]Guillermou H, De Choudens C, … Galtier FCM
  • CONCLUSIONS: Herpes zoster vaccination coverage remains low and highly unequal. Uptake is mainly driven by healthcare system organization and integration within adult immunization programs, highlighting the importance of structured vaccination policies to improve prevention worldwide.